Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis
{{output}}
Background: This study aimed to assess the efficacy and safety of MW031 in Chinese postmenopausal women with osteoporosis. Patients and methods: ... ...
